OverviewChartNewsTraderScreen

Morgan Stanley Knock-Out AMGN/  DE000ME0U4F8  /

Stuttgart
04/06/2024  08:52:23 Chg.+0.06 Bid11:52:11 Ask11:52:11 Underlying Strike price Expiration date Option type
6.00EUR +1.01% 6.15
Bid Size: 200		 6.36
Ask Size: 200		 Amgen Inc 242.0461 USD 31/12/2078 Call
GlobeNewswire 30/05 Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
TeleTrader 28/05 US markets turn to losses, Dow plunges 330 points
TeleTrader 28/05 Wall Street opens mostly higher as T+1 stock trading returns
GlobeNewswire 28/05 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 27/05 Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire 23/05 Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...
GlobeNewswire 22/05 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 22/05 Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...
GlobeNewswire 21/05 Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
GlobeNewswire 21/05 Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...
GlobeNewswire 21/05 COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer
TeleTrader 16/05 FDA approves Amgen's small cell lung cancer drug
GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 15/05 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 14/05 Accumulus Synergy Sponsors Revolutionary Healthcare Data Standard, Advancing Towards Global Dossier
GlobeNewswire 14/05 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 13/05 TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 09/05 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 09/05 argenx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
TeleTrader 08/05 US closes flat to higher with more earnings on the horizon
GlobeNewswire 08/05 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...
GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
TeleTrader 03/05 US closes higher after softer-than-expected jobs print